Statements (30)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:brand
gptkb:drug |
| gptkbp:activeIngredient |
amphetamine
|
| gptkbp:broadcastOn |
Schedule II (as amphetamine)
|
| gptkbp:chemicalClass |
amphetamine
|
| gptkbp:developedBy |
gptkb:Smith,_Kline_&_French
|
| gptkbp:form |
gptkb:tablet
inhaler |
| https://www.w3.org/2000/01/rdf-schema#label |
Benzedrine
|
| gptkbp:introducedIn |
1932
|
| gptkbp:legalStatus |
discontinued in the United States
|
| gptkbp:marketedAs |
gptkb:Benzedrine_Inhaler
gptkb:Benzedrine_Sulfate |
| gptkbp:notableFor |
first pharmaceutical amphetamine
historical recreational use use in World War II by military personnel |
| gptkbp:routeOfAdministration |
oral
inhalation |
| gptkbp:sideEffect |
addiction
anxiety insomnia increased blood pressure |
| gptkbp:usedFor |
treatment of depression
treatment of ADHD treatment of narcolepsy treatment of obesity nasal decongestion |
| gptkbp:withdrawn |
1970s
|
| gptkbp:bfsParent |
gptkb:amphetamine
|
| gptkbp:bfsLayer |
6
|